IP Library Granted Patent US 10,900,969
Granted Patent B2
US 10,900,969 · App. 15/123,156 · Granted Jan 26, 2021

Biomimetic microfluid device for capturing circulating tumor cells

Inventors: Seungpyo Hong (Naperville, IL); Ja Hye Myung (Daejeon, KR)
Assignee: UNIVERSITY OF ILLINOIS CHICAGO
G01N33/57492B01L3/5027G01N33/543B01L2300/0636B01L2300/0654B01L2300/0816B01L2300/0861B01L2300/0877
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,900,969
App. No.
15/123,156
Granted
Jan 26, 2021
Kind
B2
Abstract

A method of capturing a Circulating Tumor Cell (CTC) and Circulating Cancer Cells (CSC) from a sample includes introducing a sample into a flow based multichannel device having a cell capture surface and a flow modification surface under conditions that allow a CTC to bind to a cell rolling-inducing agent and a capturing agent disposed on the cell capture surface. The invention also provides for flow based multichannel devices to capture CTCs and CSCs from a sample.

Claims (22)

1. A microfluidic device for capturing a Circulating Tumor Cell (CTC) and a Circulating Cancer Stem Cell (CSC) from a sample, comprising:

(a) a first channel comprising a cell capture surface and a flow mobilization surface, wherein a CTC-specific or CSC-specific capturing agent and a cell rolling-inducing agent are immobilized to the cell capture surface, wherein the capturing agent is immobilized via a modified poly(amidoamine) dendrimer covalently attached to the cell capture surface agent;

(b) a second channel comprising a cell capture surface and a flow modification surface, wherein a CSC-specific or CTC-specific capturing agent and a cell rolling-inducing agent are immobilized to the cell capture surface, wherein the capturing agent is immobilized via a modified poly(amidoamine) dendrimer covalently attached to the cell capture surface agent and wherein the cell rolling-inducing agent is E-selectin or a CTC binding fragment of E-selectin.

2. The device of claim 1 , wherein the first and second channels are connected.

3. The device of claim 1 , wherein each channel has an inlet and an outlet.

4. The device of claim 1 , wherein the capturing agent is an antibody, an antibody fragment, an engineered antibody, folic acid, transferrin, a peptide, and an aptamer.

5. The device of claim 1 , wherein the capturing agent specific for CTC specifically binds a moiety on a CTC surface.

6. The device of claim 5 wherein the capturing agent is an RGD peptide.

7. The device of claim 1 wherein the capturing agent specific for CSC specifically binds a moiety on a CSC surface.

8. The device claim 1 , wherein the capturing agent is immobilized to the cell capture surface by direct attachment to the cell capture surface.

9. The device of claim 1 , wherein the capturing agent is immobilized on cell capture surface by attachment to a linker directly attached to the surface.

10. The device of claim 9 , wherein the linker is a polymeric nanolinker.

11. The device of claim 10 , wherein the polymeric nanolinker comprises a modified poly(amidoamine) dendrimer covalently attached to polyethylene glycol.

12. The device of claim 10 , wherein the polymeric nanolinker comprises polyester-n-carboxylate-1-alkyne dendron covalently attached to polyethylene glycol, wherein n is 8, 16, 32, 64, or 128.

13. The device of claim 1 , wherein the cell rolling-inducing agent and the capturing agent are arranged in a substantially uniform manner.

14. The device of claim 13 , wherein the cell capture surface of the first channel or the second channel comprises a pattern of first and second regions, the first region comprising the cell rolling-inducing agent, and the second region comprising the capture agent.

15. The device of claim 14 , wherein the first region further comprises the capture agent.

16. The device of claim 14 , wherein the first and second regions are arranged in an alternating pattern.

17. The device of claim 13 , wherein the cell capture surface of both the first channel or the second channel comprise a pattern of first and second regions, the first region comprising the cell rolling-inducing agent, and the second region comprising the capture agent.

18. The device of claim 1 , wherein the cell-rolling inducing agent is covalently attached to the cell capture surface.

19. The device of claim 1 , wherein the cell-rolling inducing agent is immobilized to a surface of the microfluidic device via a linker.

20. A method of capturing a Circulating Tumor Cell (CTC) and Circulating Cancer Stem Cell (CSC) from a sample comprising the step of introducing said sample into the device of claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2020
From: HONG, SEUNGPYO; MYUNG, JA HYE
To: UNIVERSITY OF ILLINOIS CHICAGO
Reel/Frame 053118/0645 →
CONFIRMATORY LICENSE Recorded Oct 21, 2016
From: UNIVERSITY OF ILLINOIS, CHICAGO
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 040462/0823 →
Continuity (2)
Provisional Application 61949472 · Mar 7, 2014
Related Publication 20170168063A1 · Jun 15, 2017